Results 221 to 230 of about 138,894 (338)

Neural Correlates of Cognitive Improvement After Virtual Reality‐Based Cognitive Remediation in Psychosis and Mood Disorders: A Randomized Controlled Trial

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Cognitive impairment in mood disorders and schizophrenia spectrum disorders hampers patients' clinical and functional outcomes. A key challenge in pro‐cognitive treatment development is the limited insight into the underlying neurocircuitry correlates of cognitive changes.
Viktoria Damgaard, Andreas Elleby Jespersen, Ida Kruse Søndergaard, Anders Lumbye, Maj Vinberg, Louise Birkedal Glenthøj, Merete Nordentoft, Anjali Sankar, Gitte Moos Knudsen, Julian Macoveanu, Kamilla Woznica Miskowiak   +10 more
wiley   +1 more source

Effects of Benzodiazepines on Spinal Reflexes in Cats

, 1972
Satoshi Murayama, Hiroko Uemura, Toshio Suzuki   +2 more
openalex   +1 more source

Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle

Addiction, EarlyView.
Abstract The opioid overdose epidemic remains a critical public health crisis. In recent years, synthetic opioids like fentanyl and nitazenes, have driven a sharp rise in deaths. Naloxone, an opioid receptor antagonist, has been established as a key intervention for reversing opioid overdoses and saving lives.
Mariana Gonzalez Utrilla, Edward Chesney, Joanne Neale, Nicola Metrebian, Nicola Kalk, Arne Kristian Skulberg, Paul Dietze, Martin Smith, John Strang   +8 more
wiley   +1 more source

Antiarrhytlimic effects of benzodiazepine

, 1979
Joichi Ando, Masaaki Akutagawa, Minoru Makino   +2 more
openalex   +1 more source

The landscape of ketamine use disorder: Patient experiences and perspectives on current treatment options

Addiction, EarlyView.
Abstract Aims To report the symptoms and aetiology of ketamine use disorder (KUD), gauge the effectiveness of current treatment services and identify strategies to enhance patient access and outcomes. Design Mixed‐methods, cross‐sectional questionnaire. Electronic survey from November 2023 to April 2024.
Rebecca E. Harding, Tamsin Barton, Maeve Niepceron, Ella Harris, Emily Bennett, Emily Gent, Flora Fraser, Celia J. A. Morgan   +7 more
wiley   +1 more source

Daytime Alertness, Insomnia, and Benzodiazepines [PDF]

, 1982
William C. Dement, Wesley F. Seidel, Mary A. Carskadon   +2 more
openalex   +1 more source

Benzodiazepines are Prescribed More Frequently to Patients Already at Risk for Benzodiazepine-Related Adverse Events in Primary Care

Journal of general internal medicine, 2016
David S. Kroll, H. R. Nieva, A. Barsky, J. Linder   +3 more
semanticscholar   +1 more source

Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Aim To evaluate the effectiveness, safety and cost‐effectiveness of psychosocial interventions for cannabis use disorder (CUD). Methods A systematic review of randomized controlled trials (RCTs; PROSPERO protocol CRD42024553382) of psychosocial interventions for CUD lasting >4 sessions, delivered synchronously, to individuals with CUD aged ≥16
Monika Halicka, Thomas L. Parkhouse, Katie Webster, Francesca Spiga, Lindsey A. Hines, Tom P. Freeman, Sabina Sanghera, Sarah Dawson, Craig Paterson, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +11 more
wiley   +1 more source

Pharamacological studies of a new minor tranquilizer Dipotassium chlorazepate (7-chloro-1, 3-dihidro-2-oxo-5-phenyl-1H-1, 4-benzodiazepine 3-carboxylic acid monopotassium salt monopotassium hydroxide)

, 1972
Reizo Inoki, Katsuya Iwatsubo, Tadashi Toyoda   +2 more
openalex   +2 more sources

Benzodiazepine intoxication treated with flumazenil (Anexate, RO 15–1788) [PDF]

, 1988
Lone Knudsen, Liselotte Lonka, Bente Sørensen, L Kirkegaard, O. Viborg Jensen, Svend Borup Jensen   +5 more
openalex   +1 more source